Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2023	03-2023	12-2022	09-2022	06-2022
Assets
Current Assets
Cash & Cash Equivalents	141,510	136,953	108,965	104,491	69,418
Marketable Securities	178,488	137,271	231,742	274,136	164,397
Receivables	17,043	15,373	11,339	11,732	5,590
Inventories	34,448	27,775	18,325	17,178	13,600
TOTAL	$378,947	$323,024	$374,727	$415,594	$260,945

Non-Current Assets
PPE Net	12,690	13,953	13,799	22,677	22,595
Intangibles	105,636	108,398	112,519	189,830	193,986
Other Non-Current Assets	100,262	102,426	80,855	83,490	84,357
TOTAL	$218,588	$224,777	$207,173	$295,997	$300,938

Total Assets	$597,535	$547,801	$581,900	$711,591	$561,883

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	8,345	12,996	4,546	744	13,272
Accrued Expenses	39,535	35,865	59,357	48,007	27,469
Other current liabilities	N/A	N/A	N/A	N/A	3,125
TOTAL	$74,079	$77,985	$75,682	$74,732	$77,226

Non-Current Liabilities
Long Term Debt	N/A	N/A	N/A	N/A	378,383
Deferred Revenues	5,433	6,036	6,867	12,481	10,665
Other Non-Current Liabilities	414,457	415,465	415,041	415,892	39,300
TOTAL	$496,670	$496,489	$493,618	$491,146	$487,288

Total Liabilities	$570,749	$574,474	$569,300	$565,878	$564,514

Shareholders' Equity
Shares Outstanding, K	87,955	84,040	82,800	82,274	73,106
Common Shares	88	84	82	82	73
Retained earnings	-1,881,485	-1,814,167	-1,754,374	-1,608,422	-1,523,729
Other shareholders' equity	-61	-125	-374	-460	-386
TOTAL	$26,786	$-26,673	$12,600	$145,713	$-2,631

Total Liabilities And Equity	$597,535	$547,801	$581,900	$711,591	$561,883